Stefan Riedel
Clinical Pathology · Baltimore, MDNPI 1265647838
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Abbott at 46.7% of the total.
Across 70 payments — averaging $1926.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$63K
- Opgen, Inc.$62K
- Fisher Scientific Company L.L.C.$4K
- Shionogi Inc$3K
- Cepheid$2K
- Pfizer$1K
- plus $933 from 1 others
Across 19 payments — averaging $33,236 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beckman Coulter, Inc.$591K
- Opgen, Inc.$41K
What the payments were for
- Consulting fees$77,68158%
- Speaking & faculty fees$32,70024%
- Travel & lodging$23,49117%
- Food & beverage$1,0161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 53 | $62,937 |
| Opgen, Inc. | 5 | $61,933 |
| Fisher Scientific Company L.L.C. | 2 | $3,500 |
| Shionogi Inc | 4 | $2,677 |
| Cepheid | 3 | $1,633 |
| Pfizer | 1 | $1,275 |
| BD | 2 | $933 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alinity m$52,029
- ID NOW INSTRUMENT$10,350
- Fetroja$2,677
- BRAHMS PCT KRYPTOR$2,000
- Procalcitonin$1,500
- XPERT XPRESS STREP A$500
How this compares
Too few clinical pathology providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology in Baltimore
- Thomas KicklerBaltimore$14K
- Magali FontaineBaltimore$185
- Scott KrummeyBaltimore$19
- Eric GreenBethesda$375
- Ramneesh BhatnagarLaurel$121
- Alan RemaleyBethesda$80
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.